Abhijit Dattatraya Pawar

Abhijit Dattatraya Pawar

Active Director Director DIN 02128570
DIN 02128570 First appointment May 2008 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Past companies 2 historical roles
Total affiliations 7 Since May 2008
Shareholding value •••• Premium profile

About Abhijit Dattatraya Pawar

Data last updated:

Abhijit Dattatraya Pawar is a Director at P. P. Diagnostics Private Limited (since 2008), Director at Medimap Healthcare Private Limited (since 2019) and Designated Partner at Excellence Diagnostics Llp (since 2015), and holds 2 more current directorships. The companies operate in Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹16.21 Cr; the largest is P. P. Diagnostics Private Limited at ₹11.86 Cr (FY 2025). Earlier, Abhijit Dattatraya Pawar was a Designated Partner at P. D. Diagnostics Llp (2015–2018) and Designated Partner at Jp Diagnostics Llp (from 2014).

DIN 02128570
Primary Designation Director
Industry Healthcare
First Appointment 16 May 2008
Oldest Company Age 18 yrs
Largest company P. P. Diagnostics Private Limited · ₹11.86 Cr (FY 2025)
Combined revenue ₹16.21 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
P. P. Diagnostics Private Limited U85100PN2008PTC132038
Director16 May 20082008₹11.86 Cr (FY 2025)Active
Medimap Healthcare Private Limited U85110PN2019PTC181955
Director06 Feb 20192019₹4.35 Cr (FY 2024)Active
Designated Partner18 Aug 20152015Active
Designated Partner14 Nov 20142014Active
Designated Partner11 Dec 20122012Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner05 Jun 20152015Active
Designated Partner18 Jul 20142014Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Abhijit Dattatraya Pawar

Directorship timeline

Open interactive timeline →
P. P. Diagnostics Private Limited
Medimap Healthcare Private Limited
P. S. Diagnostics Llp
Jp Diagnostics Llp
Premium access

Shareholding and investment profile for Abhijit Dattatraya Pawar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abhijit Dattatraya Pawar

Abhijit Dattatraya Pawar currently holds 5 directorships: P. P. Diagnostics Private Limited (Director, since 16 May 2008, revenue ₹11.86 Cr (FY 2025)); Medimap Healthcare Private Limited (Director, since 06 Feb 2019, revenue ₹4.35 Cr (FY 2024)); Excellence Diagnostics Llp (Designated Partner, since 18 Aug 2015); P. S. Diagnostics Llp (Designated Partner, since 14 Nov 2014); P. P. Square Diagnostics Llp (Designated Partner, since 11 Dec 2012).

Abhijit Dattatraya Pawar was first appointed on 16 May 2008 as Director at P. P. Diagnostics Private Limited. The most recent appointment on record is 06 Feb 2019 at Medimap Healthcare Private Limited.

The 2 current companies of Abhijit Dattatraya Pawar that report revenue have a combined latest revenue of ₹16.21 Cr: P. P. Diagnostics Private Limited ₹11.86 Cr (FY 2025); Medimap Healthcare Private Limited ₹4.35 Cr (FY 2024).

Abhijit Dattatraya Pawar held 2 earlier board appointments: P. D. Diagnostics Llp (Designated Partner, 05 Jun 2015 to 05 Jul 2018); Jp Diagnostics Llp (Designated Partner, from 18 Jul 2014).

The current boards of Abhijit Dattatraya Pawar's companies include Deepak Premanand Patkar (P. P. Diagnostics Private Limited), Mita Abhijit Pawar (Medimap Healthcare Private Limited), Suyog Pratap Somkuwar (P. S. Diagnostics Llp).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available